David C. Johnson

Reductions in Claudin-1 May Enhance Susceptibility to HSV-1 Infections in Atopic Dermatitis

K. Barnes, S. Georas, M. Boguniewicz, 2011 .

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

K. D. Sørensen, Ali Amin Al Olama, D. Gudbjartsson, 2019, Nature Communications.

Genetic factors influencing the risk of multiple myeloma bone disease

H. Goldschmidt, O. Stephens, B. Barlogie, 2015, Leukemia.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

G. Morgan, R. Houlston, W. Gregory, 2017, Leukemia.

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

G. Morgan, F. Ross, F. Davies, 2014, Blood Cancer Journal.

MMSET is the key molecular target in t(4;14) myeloma

D C Johnson, G. Morgan, P. Wu, 2013, Blood Cancer Journal.

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

H. Goldschmidt, G. Morgan, P. Sonneveld, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

Thomas W. Mühleisen, T. Mühleisen, M. Nöthen, 2011, Nature Genetics.

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma

N. Potter, S. H. Wilson, G. Vijayaraghavan, 2014, Leukemia.

Fine Mapping and Expression Analysis of Chromosome 1 with the Aim of Defining Critically Deregulated Genes Important in the Pathogenesis of Myeloma.

G. Morgan, D. Gonzalez, M. Jenner, 2006 .